Research Article

Antibacterial Activity of Synthetic Peptides Derived from Lactoferricin against Escherichia coli ATCC 25922 and Enterococcus faecalis ATCC 29212

Table 1

Synthetic peptides derived from lactoferricin protein. Summary of characterization (RP-HPLC and MALDI-TOF MS) and antibacterial activity of purified products.

GroupPeptide codeSequenceRP-HPLC
(min)
MALDI-TOF MSE.  coli
ATCC 25922
E.  faecalis
ATCC 29212
Theoretical
Mol wt
Experimental
m/z. [M + H]+
MIC (M)MCB (M)MIC (M)MCB (M)

IIRRWQWR 16,73985,54986,92101,5101,5202,9202,9
I.1RRWQWR16,281057,561057,2794,6189,1189,1189,1
I.2RWQWRWQWR22,841485,751487,1226,933,726,933,7
I.3RWQWRWQWR22,471556,791558,1664,264,232,132,1
I.4((RRWQWR)2KC)220,004596,642300,57a4,44,410,910,9

IIII.1 17FK19CRRWQWRMKKLG31A19,301993,491995,0225,125,125,125,1
II.2FKRRWQWRMKK17,421718,971721,1229,129,1116,3116,3
II.3FK RRWQWRMKK17,811718,971720,81116,3116,358,2116,3
II.4FK RRWQWRM19,511462,781464,7334,234,268,4136,7
II.5FKRRWQWRM19,171462,781464,5168,4136,7136,7136,7
II.6FK RWQWRM20,131420,751420,9370,470,4140,8140,8
II.7FK WQWRM23,141377,721377,9145,2145,2145,2145,2
II.8RRWQWRMKKLG18,311542,871545,1232,432,464,8129,6
II.9RRWQWRMKKLG18,191613,911615,3123,9123,962,0123,9
II.10RRWQWRMLG18,521669,921672,6459,959,915,029,9
II.11RRWQWRMKK17,171443,801445,0869,369,369,369,3

IIIIII.1 20GRRRRSVQWC30A16,001372,731373,618,236,472,8145,7
III.2GRRRRSVQWCA14,811516,761515,9865,965,965,9131,9
III.3GRRRRSVQWCA15,151445,681144,9369,2138,369,2138,3
III.4GRRRRSVQWCA15,201443,761444,8217,334,669,3138,5

IVIV.1FKCRRWQWRMKKLGAPSITCVRRAE19,123104,663106,1532,232,232,232,2
IV.2LF protein8000025,025,025,025,0
IV.3ITEVEPEDIDT15,021258,581259,991589,11589,11589,11589,1

This signal corresponds to the dimer before oxidation (see Figure 2). The reported antimicrobial LfcinB center [24, 25] is underlined and changes in amino acid sequences are in box.